1 Clinic

Search documents
111, Inc. Announces First Quarter 2025 Unaudited Financial Results
Prnewswireยท 2025-06-19 07:03
Core Viewpoint - 111, Inc. reported stable net revenues of RMB 3.5 billion (US$486.3 million) for Q1 2025, reflecting resilience in a challenging macroeconomic environment [4][5][7] - The company achieved a 4.8% year-over-year reduction in total operating expenses, improving operational efficiency [4][7][19] - The strategic focus remains on leveraging technology to enhance the healthcare value chain, with continued investments in AI and digital solutions [4][5] Financial Performance - Net revenues for Q1 2025 were RMB 3,529 million (US$486.3 million), a slight increase of 0.02% from RMB 3,528 million in Q1 2024 [5][31] - Gross segment profit decreased by 6.4% year-over-year to RMB 195.1 million (US$26.9 million) due to unfavorable macroeconomic conditions [5][31] - Operating expenses totaled RMB 195.0 million (US$26.9 million), down 4.8% from RMB 204.8 million in the same quarter last year, with operating expenses as a percentage of net revenues decreasing to 5.5% [7][9][19] Operational Highlights - The company maintained quarterly operational profitability with income from operations of RMB 0.1 million (US$0.02 million), down from RMB 3.7 million in the same quarter last year [7][11] - Non-GAAP income from operations was RMB 4.3 million (US$0.6 million), compared to RMB 8.9 million in the same quarter of last year [12][32] - Net cash from operating activities was RMB 112.6 million (US$15.5 million), indicating positive operating cash flow for the quarter [7][31] Cost Management - Selling and marketing expenses decreased by 15.5% year-over-year to RMB 67.9 million (US$9.4 million) [9][10] - Technology expenses were reduced by 15.6% to RMB 15.5 million (US$2.1 million) [19] - General and administrative expenses decreased by 3.8% to RMB 18.3 million (US$2.5 million) [19] Balance Sheet and Cash Position - As of March 31, 2025, the company held cash and cash equivalents, restricted cash, and short-term investments totaling RMB 556.8 million (US$76.7 million), an increase from RMB 518.3 million at the end of 2024 [17][29] - Total current assets decreased to RMB 2,485.2 million (US$342.5 million) from RMB 2,649.7 million at the end of 2024 [29] - Total liabilities decreased to RMB 2,230.0 million (US$307.3 million) from RMB 2,406.9 million at the end of 2024 [29]